Q2 Results Live: Pfizer's One-Time Gain Lifts Profit; SBI Asset Quality Improves; Solar Industries Profit Zooms 79%
State Bank of India is in focus in a quarterly results development.
· NDTV Profit
A packed earnings calendar awaits investors, with heavyweight names including SBI, NSE, Bajaj Finserv, MCX, Lupin, Solar Industries, Emcure Pharmaceuticals and Bata India set to unveil their quarterly scorecards.
The analysis
State Bank of India reported movement of 79%. Those are the figures as filed — what moves the price is how they sit against what the market already expected, not their absolute size.
Against that, the stock is +1.2% on the day at ₹1,018.50, and has returned -6.1% over three months. It sits 17% below its 52-week high. The banks sector has moved -2.8% over the same period, so State Bank of India is running 3.3 points behind its peers.
For State Bank of India, the question is how much of this is already reflected in the price and how much re-rates the banks peer set alongside it.
Why it matters
- Earnings versus expectations is what actually re-rates a stock; the surprise matters more than the absolute number.
- The shift to renewables is redrawing which energy names are structural winners versus stranded.
- With NSE involved, this carries a regulatory dimension that can outlast the immediate market reaction.
Market context
- The 5 companies named span 5 sectors, so these are separate company stories rather than one sector-wide move.
- On the day, 4 of 5 are higher: Bajaj Finserv leads at +1.6% and Emcure Pharmaceuticals trails at -1.4%.
- Over three months: State Bank of India (SBI) -6.1% against Banks -2.8% (3.3 points behind); Solar Industries India +0.6% against Defence & Aerospace -5.5% (6.1 points ahead); Bajaj Finserv -10.6% against Financial Services -10.2% (0.4 points behind); Emcure Pharmaceuticals +14.3% against Pharma & Healthcare +1.4% (12.9 points ahead).
- At least 25% below the 52-week high: Bata India (40%).
| Company | Price | Day | 1M | 3M | From 52-wk high | Volume vs 20-day | Market cap |
|---|---|---|---|---|---|---|---|
| State Bank of India (SBI)SBIN · Banks | ₹1,018.50 | +1.2% | +6.2% | -6.1% | -17.0% | 1.4× | — |
| Solar Industries IndiaSOLARINDS · Defence & Aerospace | ₹18,608.00 | +0.5% | -7.3% | +0.6% | -17.1% | 1.3× | — |
| Bajaj FinservBAJAJFINSV · Financial Services | ₹1,864.70 | +1.6% | +6.4% | -10.6% | -12.0% | 0.7× | — |
| Emcure PharmaceuticalsEMCURE · Pharma & Healthcare | ₹2,212.80 | -1.4% | +15.1% | +14.3% | -1.4% | 1.0× | — |
| Bata IndiaBATAINDIA · Consumer & Retail | ₹638.05 | +0.1% | +2.9% | -12.4% | -39.9% | 0.6× | — |
Banks
1M +2.0% · 3M -2.8%
State Bank of India (SBI)
Defence & Aerospace
1M -6.0% · 3M -5.5%
Solar Industries India
Financial Services
1M -0.2% · 3M -10.2%
Bajaj Finserv
Pharma & Healthcare
1M +3.0% · 3M +1.4%
Emcure Pharmaceuticals
Prices as of 6 Nov 2026, 16:11 IST. Sector moves are the average of the stocks we track in each sector.
In this story
Related coverage
Emcure Pharma shares jump 7% after Q2 profit rises 29% YoY to Rs 325 crore
Diwali dhamaka stocks: Eternal, ICICI Bank, among 10 with upside of up to 34%
Great Diwali stock hunt: HAL, Eternal, 5 other stocks with upside of up to 75%
Largecap dhamaka! 6 bluechip stocks with upside of up to 48% to buy this Diwali
Aster DM Quality Care Q2 net profit more than doubles to ₹262 crore